Imunon, Inc.
IMNN
$1.59
$0.085.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -37.33% | -- | |||
| Gross Profit | 37.33% | -- | |||
| SG&A Expenses | -32.62% | 11.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.18% | 1.05% | |||
| Operating Income | 35.18% | -1.05% | |||
| Income Before Tax | 33.77% | -0.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.77% | -0.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.77% | -0.62% | |||
| EBIT | 35.18% | -1.05% | |||
| EBITDA | 35.76% | -1.19% | |||
| EPS Basic | 35.93% | 41.46% | |||
| Normalized Basic EPS | 36.36% | 41.46% | |||
| EPS Diluted | 35.93% | 41.46% | |||
| Normalized Diluted EPS | 36.36% | 41.46% | |||
| Average Basic Shares Outstanding | 4.05% | 71.89% | |||
| Average Diluted Shares Outstanding | 4.05% | 71.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||